Found: 6
Select item for more details and to access through your institution.
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1).
- Published in:
- Rheumatology, 2020, v. 59, n. 10, p. 2774, doi. 10.1093/rheumatology/kez684
- By:
- Publication type:
- Article
Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.
- Published in:
- Rheumatology, 2015, v. 54, n. 7, p. 1210, doi. 10.1093/rheumatology/keu438
- By:
- Publication type:
- Article
Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 8, p. 1601, doi. 10.1111/head.13897
- By:
- Publication type:
- Article
Spinal Inflammation in the Absence of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in Patients With Active Nonradiographic Axial Spondyloarthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, n. 3, p. 667, doi. 10.1002/art.38283
- By:
- Publication type:
- Article
Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies.
- Published in:
- Neurology & Therapy, 2020, v. 9, n. 2, p. 459, doi. 10.1007/s40120-020-00185-5
- By:
- Publication type:
- Article